The 9-month patency rate was 92.9%. The Covered Balloon Expandable Stent (COBEST) trial is an ongoing prospective randomized trial of 123 patients, randomized to the Atrium V12 ® covered stent ...

Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

Citation: Stenting improves long-term survival for patients with complete blockages undergoing percutaneous coronary intervention (2025, May 1) retrieved 4 May 2025 from https://medicalxpress.com ...

covered stents, and innovative balloon catheters. Approximately 75% of the acquired revenues stem from coronary interventions ...